title: The lost hope of elimination of Kala-azar (visceral leishmaniasis) by 2010 and cyclic occurrence of its outbreak in India, blame falls on vector control practices or co-infection with human immunodeficiency virus or therapeutic modalities?
abstract: The Kala-azar/visceral leishmaniasis (VL) turns epidemic form once in every 15 years in the endemic regions of Indian subcontinent. The goal of elimination of Kala-azar from India by 2010 was lost despite paramount efforts taken by the Government of India and World Health Organization and Regional Office for South East Asia. The main objective of this review was to elucidate the possible reason for the failure of Kala-azar elimination program and to suggest possible remedial measures to achieve the goal in future. The annual numbers of VL cases and deaths recorded in India since 1977 were plotted on a graph, to see if the temporal trends could be associated with changes in the vector control practices or co-infection with human immunodeficiency virus (HIV) or therapeutic modalities used against VL. The VL cases flares up whenever the effect of dichlorodiphenyltrichloroethane (DDT) diminished after the withdrawal of spray. The fading effectiveness was clearly correlated with an increasing number of VL cases. Therapeutic modalities were found to be highly correlating with VL mortality not with VL morbidity. The diminishing efficacy of first and second line drugs and the introduction of new drugs and drugs combination were responsible for ups and downs in the VL mortality. The VL mortality is constantly declining since 1993, but cases started increasing from 2003 to 2007 and then recently again from 2010 to 2011. This shows a serious lacuna in the vector control practices applied. The extent of HIV co-infection did not show any correlation with number/trend of VL cases or death over the study period. It is concluded that, by strict vector control practices, the VL cases can be reduced and by applying proper therapeutic strategies, the VL mortality can be reduced. HIV-VL co-infection does not seem to be in a worried stage.
authors.affiliation: Department of Health Research, Microbiology Division, Centre for Research in Medical Entomology, Indian Council of Medical Research, Madurai, Tamil Nadu, India.
authors.forename: Mayilsamy
authors.initials: M
authors.lastname: Muniaraj
keywords: Co-infection; Kala-azar; cyclic occurrence; elimination; human immunodeficiency virus; therapeutic modalities; vector control practices; visceral leishmaniasis
references.citation: Trans R Soc Trop Med Hyg. 2012 Dec;106(12):770-2
references.pmid: 23102868
references.citation: Indian J Med Res. 1981 Jan;73 Suppl:1-18
references.pmid: 6897932
references.citation: PLoS Negl Trop Dis. 2010 Oct 26;4(10):e859
references.pmid: 21049013
references.citation: Indian J Med Res. 2007 Nov;126(5):447-51
references.pmid: 18160749
references.citation: Clin Diagn Lab Immunol. 2002 Sep;9(5):951-8
references.pmid: 12204943
references.citation: PLoS Negl Trop Dis. 2012;6(12):e1974
references.pmid: 23285310
references.citation: Nat Rev Microbiol. 2007 Nov;5(11):873-82
references.pmid: 17938629
references.citation: Clin Infect Dis. 2000 Oct;31(4):1104-7
references.pmid: 11049798
references.citation: Indian J Med Res. 2006 Mar;123(3):331-44
references.pmid: 16778314
references.citation: Am J Trop Med Hyg. 2010 Aug;83(2):357-64
references.pmid: 20682882
references.citation: J Vector Borne Dis. 2008 Jun;45(2):105-11
references.pmid: 18592839
references.citation: J Theor Biol. 2010 Jan 7;262(1):177-85
references.pmid: 19769990
references.citation: Lancet. 2011 Feb 5;377(9764):477-86
references.pmid: 21255828
references.citation: Lancet Infect Dis. 2010 Mar;10(3):184-94
references.pmid: 20185097
references.citation: J Clin Microbiol. 2011 Aug;49(8):3088-91
references.pmid: 21613432
references.citation: Natl Med J India. 1999 Mar-Apr;12(2):62-8
references.pmid: 10416321
references.citation: Clin Infect Dis. 1997 Apr;24(4):684-703
references.pmid: 9145744
references.citation: World Health Organ Tech Rep Ser. 1984;701:1-140
references.pmid: 6428052
references.citation: Indian J Med Res. 2010 Sep;132:337-8
references.pmid: 20847382
references.citation: Trans R Soc Trop Med Hyg. 2000 Jul-Aug;94(4):429-31
references.pmid: 11127250
references.citation: Indian J Med Res. 2009 Jan;129(1):102-4
references.pmid: 19287067
references.citation: Natl Med J India. 1993 Mar-Apr;6(2):57-60
references.pmid: 8477209
references.citation: J Vector Borne Dis. 2009 Sep;46(3):225-9
references.pmid: 19724087
references.citation: Clin Infect Dis. 2011 Oct;53(7):e91-8
references.pmid: 21890763
references.citation: J Glob Infect Dis. 2010 May;2(2):151-8
references.pmid: 20606971
references.citation: Mem Inst Oswaldo Cruz. 2009 Nov;104(7):1019-22
references.pmid: 20027471
references.citation: Indian J Med Res. 2006 Mar;123(3):389-98
references.pmid: 16778318
references.citation: Clin Microbiol Rev. 2008 Apr;21(2):334-59, table of contents
references.pmid: 18400800
references.citation: Clin Infect Dis. 2012 Aug;55(4):543-50
references.pmid: 22573856
references.citation: J Acquir Immune Defic Syndr. 2003 Apr 15;32(5):572-3
references.pmid: 12679712
references.citation: Trans R Soc Trop Med Hyg. 1983;77(2):167-70
references.pmid: 6868096
references.citation: Trop Med Int Health. 2006 Jun;11(6):899-905
references.pmid: 16772012
references.citation: Bull World Health Organ. 1998;76(1):25-32
references.pmid: 9615494
references.citation: Trends Parasitol. 2006 Dec;22(12):552-7
references.pmid: 17023215
references.citation: World Health Organ Tech Rep Ser. 1990;793:1-158
references.pmid: 2124015
references.citation: Indian J Med Res. 1979 Oct;70:563-70
references.pmid: 541003
references.citation: N Engl J Med. 2007 Jun 21;356(25):2571-81
references.pmid: 17582067
references.citation: Indian J Med Res. 2006 Mar;123(3):467-72
references.pmid: 16778324
references.citation: BMJ. 1998 Apr 18;316(7139):1200-5
references.pmid: 9583927
references.citation: Br Med J (Clin Res Ed). 1984 Mar 24;288(6421):895-7
references.pmid: 6322906
references.citation: Trop Med Int Health. 2001 Nov;6(11):849-54
references.pmid: 11703838
references.citation: J Med Microbiol. 2006 Jul;55(Pt 7):919-922
references.pmid: 16772420
references.citation: Indian J Med Res. 2006 Mar;123(3):195-6
references.pmid: 16778303
references.citation: J Trop Med. 2011;2011:645203
references.pmid: 22174722
references.citation: J Commun Dis. 1999 Jun;31(2):73-7
references.pmid: 10810593
references.citation: Indian J Med Res. 1991 Mar;93:103-10
references.pmid: 1649790
references.citation: Bull World Health Organ. 2001;79(8):793
references.pmid: 11545338
references.citation: Am J Trop Med Hyg. 1998 Jul;59(1):139-43
references.pmid: 9684642
references.citation: J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):115-6
references.pmid: 12514423
references.citation: Lancet Infect Dis. 2002 Aug;2(8):494-501
references.pmid: 12150849